Andreas Wolf

4.1k total citations · 1 hit paper
40 papers, 2.6k citations indexed

About

Andreas Wolf is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Andreas Wolf has authored 40 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 14 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in Andreas Wolf's work include Monoclonal and Polyclonal Antibodies Research (14 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (5 papers). Andreas Wolf is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (14 papers), CAR-T cell therapy research (10 papers) and Immunotherapy and Immune Responses (5 papers). Andreas Wolf collaborates with scholars based in Germany, United States and United Kingdom. Andreas Wolf's co-authors include Patrick A. Baeuerle, Peter Kufer, Christian Brandl, Matthias Klinger, Gerhard Zugmaier, Andreas Viardot, Mariele Goebeler, Ralf C. Bargou, Gert Riethmüller and Margit Schmidt and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Clinical Oncology.

In The Last Decade

Andreas Wolf

40 papers receiving 2.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor Regression in Cancer Patients by Very Low Doses of a T Cell–Engaging Antibody

2008 798 citations Gerhard Zugmaier, Matthias Klinger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Wolf Germany	22	1.5k	955	835	629	373	40	2.6k
Wolfgang Oster Germany	28	760 0.5×	489 0.5×	791 0.9×	674 1.1×	118 0.3×	101	3.0k
Véronique Duchatelle France	18	571 0.4×	772 0.8×	1.6k 1.9×	700 1.1×	47 0.1×	42	3.7k
Linda K. Myers United States	31	430 0.3×	816 0.9×	1.4k 1.7×	651 1.0×	54 0.1×	102	3.2k
Farkas Vánky Sweden	27	806 0.5×	343 0.4×	1.3k 1.6×	404 0.6×	68 0.2×	104	2.6k
N. Miyasaka Japan	25	406 0.3×	302 0.3×	939 1.1×	420 0.7×	82 0.2×	76	2.8k
Vasileios C. Kyttaris United States	42	885 0.6×	459 0.5×	3.8k 4.6×	918 1.5×	54 0.1×	116	5.2k
William H. West United States	16	1.0k 0.7×	280 0.3×	1.6k 1.9×	387 0.6×	52 0.1×	36	2.6k
Albrecht Reichle Germany	27	1.8k 1.2×	235 0.2×	488 0.6×	1.0k 1.6×	1.5k 4.0×	125	3.8k
Consuelo Blosch United States	8	485 0.3×	237 0.2×	571 0.7×	509 0.8×	64 0.2×	11	2.1k
Tong Zhou United States	26	473 0.3×	411 0.4×	1.5k 1.8×	1.3k 2.0×	51 0.1×	68	2.9k

Countries citing papers authored by Andreas Wolf

Since Specialization

Citations

This map shows the geographic impact of Andreas Wolf's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Wolf with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Wolf more than expected).

Fields of papers citing papers by Andreas Wolf

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Wolf. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Wolf. The network helps show where Andreas Wolf may publish in the future.

Co-authorship network of co-authors of Andreas Wolf

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Wolf. A scholar is included among the top collaborators of Andreas Wolf based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Wolf. Andreas Wolf is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zeymer, Uwe, Andreas Wolf, Frank Richard, et al.. (2020). Use, Persistence, Efficacy, and Safety of Apixaban in Patients with Non-Valvular Atrial Fibrillation in Unselected Patients in Germany. Results of the Prospective Apixaban in Atrial Fibrillation (APAF) Registry. Cardiology and Therapy. 9(2). 467–478. 5 indexed citations

Hijazi, Youssef, Matthias Klinger, Benjamin Wu, et al.. (2018). Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma. Current Clinical Pharmacology. 13(1). 55–64. 21 indexed citations

Zugmaier, Gerhard, Chris Holland, Youssef Hijazi, et al.. (2017). Changes in clinical laboratory parameters and pharmacodynamic markers in response to blinatumomab treatment of patients with relapsed/refractory ALL. Experimental Hematology and Oncology. 6(1). 14–14. 53 indexed citations

Zhu, Min, Benjamin Wu, Christian Brandl, et al.. (2016). Blinatumomab, a Bispecific T-cell Engager (BiTE®) for CD-19 Targeted Cancer Immunotherapy: Clinical Pharmacology and Its Implications. Clinical Pharmacokinetics. 55(10). 1271–1288. 157 indexed citations

Siegert, Sabine, Andreas Wolf, D.N. Cooper, Michael Krawczak, & Michael Nothnagel. (2015). Mutations Causing Complex Disease May under Certain Circumstances Be Protective in an Epidemiological Sense. PLoS ONE. 10(7). e0132150–e0132150. 3 indexed citations

Taudien, Stefan, Gábor Gäbel, Oliver Kuß, et al.. (2012). Association studies of the copy-number variable ß-defensin cluster on 8p23.1 in adenocarcinoma and chronic pancreatitis. BMC Research Notes. 5(1). 629–629. 11 indexed citations

Nothnagel, Michael, Alexander Herrmann, Andreas Wolf, et al.. (2011). Technology-specific error signatures in the 1000 Genomes Project data. Human Genetics. 130(4). 505–516. 29 indexed citations

Wolf, Andreas, Amke Caliebe, Nick Thomas, et al.. (2011). Single base-pair substitutions at the translation initiation sites of human genes as a cause of inherited disease. Human Mutation. 32(10). 1137–1143. 26 indexed citations

Nothnagel, Michael, Andreas Wolf, Alexander Herrmann, et al.. (2010). Statistical inference of allelic imbalance from transcriptome data. Human Mutation. 32(1). 98–106. 16 indexed citations

10.

Marschner, Norbert, Dominik Rüttinger, Gerhard Zugmaier, et al.. (2010). Phase II Study of the Human Anti-Epithelial Cell Adhesion Molecule Antibody Adecatumumab in Prostate Cancer Patients with Increasing Serum Levels of Prostate-Specific Antigen after Radical Prostatectomy. Urologia Internationalis. 85(4). 386–395. 29 indexed citations

11.

Kirsch, Stefan, Juan J. Pasantes, Andreas Wolf, et al.. (2008). Chromosomal evolution of the PKD1 gene family in primates. BMC Evolutionary Biology. 8(1). 263–263. 9 indexed citations

12.

Bosy‐Westphal, Anja, Andreas Wolf, Britta Hitze, et al.. (2008). Familial influences and obesity-associated metabolic risk factors contribute to the variation in resting energy expenditure: the Kiel Obesity Prevention Study. American Journal of Clinical Nutrition. 87(6). 1695–1701. 38 indexed citations

13.

Wolf, Andreas, David Millar, Amke Caliebe, et al.. (2008). A gene conversion hotspot in the human growth hormone (GH1) gene promoter. Human Mutation. 30(2). 239–247. 12 indexed citations

14.

Brischwein, Klaus, Bernd Schlereth, Andreas Wolf, et al.. (2005). MT110: A novel bispecific single-chain antibody construct with high efficacy in eradicating established tumors. Molecular Immunology. 43(8). 1129–1143. 212 indexed citations

15.

Wolf, Andreas, Amke Caliebe, Olaf Junge, & Michael Krawczak. (2004). Forensic interpretation of Y-chromosomal DNA mixtures. Forensic Science International. 152(2-3). 209–213. 14 indexed citations

16.

Mayer, Petra, Andreas Wolf, Frank Hanakam, et al.. (2002). In vitro and in vivo activity of MT201, a fully human monoclonal antibody for pancarcinoma treatment. International Journal of Cancer. 100(1). 101–110. 87 indexed citations

17.

Wolf, Andreas & Stanley G. Rockson. (1998). Myocardial ischemia and infarction due to multiple coronary-cameral fistulae: Two case reports and review of the literature. Catheterization and Cardiovascular Diagnosis. 43(2). 179–183. 21 indexed citations

18.

Wolf, Andreas, Christoff Zalpour, Gregor Theilmeier, et al.. (1997). Dietary l-Arginine Supplementation Normalizes Platelet Aggregation in Hypercholesterolemic Humans. Journal of the American College of Cardiology. 29(3). 479–485. 146 indexed citations

19.

Theilmeier, Gregor, Christoff Zalpour, Adrian Ma, et al.. (1995). 765-4 Adhesiveness of Mononuclear Cells is Increased in Hypercholesterolemic Humans, and Reduced by the NO Precursor. Journal of the American College of Cardiology. 25(2). 276A–276A. 2 indexed citations

20.

Saito, Takashi, et al.. (1989). Correlation of lysophosphatidylcholine-induced vs spontaneous relaxation to cyclic GMP levels in rabbit thoracic aorta. Life Sciences. 44(9). 611–618. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact